Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.251
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
0.255
+0.004 (1.43%)
After-hours: Mar 9, 2026, 7:11 PM EDT
Akari Therapeutics, Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 11 | 32 | 18 | 35 | 71 | 71 | |
| Market Cap Growth | -55.71% | 83.11% | -49.58% | -51.00% | 0.31% | 93.59% | |
| Enterprise Value | 11 | 31 | 10 | 27 | 58 | 59 | |
| Last Close Price | 0.25 | 1.22 | 3.12 | 9.40 | 30.00 | 37.00 | |
| PB Ratio | 0.36 | 1.45 | -77.02 | 19.53 | 12.85 | 7.59 | |
| P/TBV Ratio | - | - | - | 19.72 | 12.91 | 7.61 | |
| Debt / Equity Ratio | 0.10 | 0.15 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.01 | 0.03 | 16.79 | -7.40 | -1.68 | -1.50 | |
| Net Debt / EBITDA Ratio | 0.02 | -0.04 | 0.23 | 0.57 | 0.54 | 0.78 | |
| Net Debt / FCF Ratio | 0.03 | -0.05 | 0.23 | 0.62 | 0.50 | 0.83 | |
| Quick Ratio | 0.16 | 0.13 | 0.84 | 1.10 | 1.54 | 2.69 | |
| Current Ratio | 0.19 | 0.15 | 0.95 | 1.15 | 1.91 | 2.79 | |
| Return on Equity (ROE) | -197.24% | -179.92% | -1281.43% | -483.23% | -233.27% | -363.75% | |
| Return on Assets (ROA) | -34.20% | -37.89% | -115.51% | -113.26% | -81.96% | -106.60% | |
| Return on Capital Employed (ROCE) | -44.20% | -54.30% | 7338.90% | -1289.10% | -309.90% | -191.60% | |
| Earnings Yield | -138.70% | -61.28% | -56.74% | -50.73% | -24.40% | -24.00% | |
| FCF Yield | -84.87% | -38.87% | -93.17% | -61.47% | -26.40% | -23.82% | |
| Buyback Yield / Dilution | -238.34% | -144.03% | -56.79% | -45.46% | -35.87% | -72.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.